Invasive Aspergillosis Terminated Phase 2 Trials for Micafungin (DB01141)

IndicationStatusPhase
DBCOND0031838 (Invasive Aspergillosis)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00376337Micafungin Salvage Mono-therapy in Invasive AspergillosisTreatment